KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Operating Expenses: 2010-2024

Historic Operating Expenses for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $6.5 million.

  • TherapeuticsMD's Operating Expenses fell 2.08% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 45.31%. This contributed to the annual value of $6.5 million for FY2024, which is 33.63% down from last year.
  • Latest data reveals that TherapeuticsMD reported Operating Expenses of $6.5 million as of FY2024, which was down 33.63% from $9.8 million recorded in FY2023.
  • TherapeuticsMD's Operating Expenses' 5-year high stood at $204.4 million during FY2020, with a 5-year trough of $6.5 million in FY2024.
  • For the 3-year period, TherapeuticsMD's Operating Expenses averaged around $27.9 million, with its median value being $9.8 million (2023).
  • Its Operating Expenses has fluctuated over the past 5 years, first rose by 5.10% in 2020, then crashed by 85.42% in 2023.
  • Yearly analysis of 5 years shows TherapeuticsMD's Operating Expenses stood at $204.4 million in 2020, then tumbled by 60.50% to $80.7 million in 2021, then dropped by 16.56% to $67.4 million in 2022, then tumbled by 85.42% to $9.8 million in 2023, then tumbled by 33.63% to $6.5 million in 2024.